Allergan Ligand Retinoid Therapeutics Inc, Ligand Pharmaceuticals Inc, Allergan Inc deal

LGND and Allergan will buy back their ALRI joint venture. LGND will pay $71.4 million ($21.97 per share) and Allergan will pay LGND $8.9 million to acquire a one-half interest in the assets of ALRI (s...